ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, according to a large study released on Sunday. The 9,306-patient study tested Starlix, known chemically as nateglinide, and the big-selling Novartis blood pressure medicine Diovan. Diovan, known ...

A federal judge in Nashville has refused to dismiss 40 lawsuits against a Swedish-based pharmaceutical company accused of failing to warn patients that two of its drugs can cause severe deterioration of the jaw. U.S. District Judge Todd Campbell's ruling last week is the latest ...

AMSTERDAM (Reuters) - The Dutch government wants to sell 21 million unused H1N1 flu vaccine doses back to their manufacturers after they proved unnecessary and no other country wanted to buy them, the Health Ministry said on Saturday. A spokeswoman for the ministry said it had approached manufacturers GlaxoSmithKline and Novartis about buying back the doses. She added that it was ...

Shares of biotechnology company Nektar Therapeutics Inc. jumped Wednesday as analysts brushed off the report of a fourth-quarter loss and focused instead on the company's pipeline of products. The stock rose $1.53, or 12 percent, to $14.06 in afternoon trading. Shares earlier reached a 52-week ...